Quercetin-primed BMSC-derived extracellular vesicles ameliorate chronic liver damage through miR-136-5p and GNAS/STAT3 signaling pathways
International Immunopharmacology · 2024
DOI: 10.1016/j.intimp.2024.113162 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2024. Verfasst von Xiaodan Jiang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Suzhou TCM Hospital Affiliated to Nanjing University of Chinese Medicine, China. Hauptthemen laut MEDLINE: Extracellular Vesicles, STAT3 Transcription Factor, MicroRNAs, Quercetin. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Beijing Municipality.
Abstract (Originalsprache)
BACKGROUND: Chronic liver damage (CLD) is a long-term and progressive liver condition characterized by inflammation, fibrosis, and impaired liver function, which ultimately lead to severe complications such as cirrhosis or liver cancer. Quercetin (Que), a flavonoid in various plants, possesses anti-inflammatory, antiviral, anti-ischemic, and anticancer properties. Recently, extracellular vesicles (EVs) derived from pretreated bone marrow mesenchymal stem cells (BMSCs) have shown immense potential in treating various diseases, including CLD. Thus, this study evaluated the regulatory effects of Que-preconditioned BMSC-derived EVs (Que-EVs) on LPS-stimulated RAW264.7 cells and their therapeutic effects on mice with CLD. METHODS: Que-EVs and control-EVs were harvested from the cell culture supernatant of BMSCs. The EVs were characterized using western blot, transmission electron microscopy, and nanoparticle tracking analysis. Further, the DIR labeling of EVs was used to detect in vitro and in vivo uptake. Next, LPS pre-stimulated RAW264.7 cells were treated with Que-EVs and control-EVs for 24 h. The relative expression of inflammatory cytokines and macrophage polarization markers genes was assessed using RT-qPCR, and western blot was conducted to evaluate the GNAS, PI3K, ERK, and STAT3 gene and protein expressions in RAW264.7 cells. Furthermore, transfection techniques were employed to induce miR-136-5p inhibition and GNAS overexpression in RAW264.7 cells to validate the role of miR-136-5p in alleviating inflammation through the GNAS/PI3K/ERK/STAT3 pathway. Subsequently, the outcomes were validated via in vitro experiments. RESULTS: Que enhanced miR-136-5p expression in BMSC-EVs. Furthermore, it was shown that EVs delivered miR-136-5p to macrophages, thereby attenuating M1-type macrophage polarisation through the GNAS/PI3K/ERK/STAT3 pathway, reducing liver inflammation, improving liver function and treating CLD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Suzhou TCM Hospital Affiliated to Nanjing University of Chinese Medicine, China.
- School of Traditional Chinese Medicine, Capital Medical University, Beijing, China.
- School of Basic Medical Sciences, Capital Medical University, Beijing, China.
- School of Traditional Chinese Medicine, Capital Medical University, Beijing, China. Electronic address: wenlanliu1900@126.com.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Beijing Municipality
Zitieren
APA
Jiang, X., Liu, Z., You, H., Tang, Z., Ma, Y., Nie, R., Yang, Z., Che, N., & Liu, W. (2024). Quercetin-primed BMSC-derived extracellular vesicles ameliorate chronic liver damage through miR-136-5p and GNAS/STAT3 signaling pathways. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2024.113162
Vancouver
Jiang X, Liu Z, You H, Tang Z, Ma Y, Nie R, et al. Quercetin-primed BMSC-derived extracellular vesicles ameliorate chronic liver damage through miR-136-5p and GNAS/STAT3 signaling pathways. International Immunopharmacology. 2024. doi:10.1016/j.intimp.2024.113162
BibTeX
@article{Jiang2024,
author = {Jiang, Xiaodan and Liu, Zhejun and You, Hongjie and Tang, Zuoqing and Ma, Yun and Nie, Ruifang and Yang, Zheng and Che, Niancong and Liu, Wenlan},
title = {Quercetin-primed BMSC-derived extracellular vesicles ameliorate chronic liver damage through miR-136-5p and GNAS/STAT3 signaling pathways},
journal = {International Immunopharmacology},
year = {2024},
doi = {10.1016/j.intimp.2024.113162}
}
EUVIMED